Neoceptors: reengineering GPCRs to recognize tailored ligands
- 31 March 2007
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 28 (3), 111-116
- https://doi.org/10.1016/j.tips.2007.01.006
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The A2B adenosine receptor protects against inflammation and excessive vascular adhesionJCI Insight, 2006
- Random Mutagenesis of the Human Adenosine A2B Receptor Followed by Growth Selection in Yeast. Identification of Constitutively Active and Gain of Function MutationsMolecular Pharmacology, 2004
- A1adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusionAmerican Journal of Physiology-Renal Physiology, 2004
- Protection from ischemic liver injury by activation of A2Aadenosine receptors during reperfusion: inhibition of chemokine inductionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Design of a Novel Globular Protein Fold with Atomic-Level AccuracyScience, 2003
- Three-dimensional representations of G protein-coupled receptor structures and mechanismsMethods in Enzymology, 2002
- Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damageNature, 2001
- Engineering Orthogonal Ligand−Receptor Pairs from “Near Drugs”Journal of the American Chemical Society, 2001
- Neoceptor Concept Based on Molecular Complementarity in GPCRs: A Mutant Adenosine A3 Receptor with Selectively Enhanced Affinity for Amine-Modified NucleosidesJournal of Medicinal Chemistry, 2001
- The estrogen receptor: a structure-based approach to the design of new specific hormone–receptor combinationsCell Chemical Biology, 2001